Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News 4D Molecular Therapeutics Inc FDMT

Consumer Cyclical Healthcare Advertising Agencies Biotechnology
4D Molecular Therapeutics, Inc. is a clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat diseases in ophthalmology and pulmonology. The Company has a portfolio of genetic medicine product candidates, with five product candidates in clinical trials in seven patient populations: 4D-150 for the treatment of wet age-related macular... see more

Recent & Breaking News (NDAQ:FDMT)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 4D Molecular Therapeutics, Inc. - FDMT

Accesswire July 30, 2024

Levi & Korsinsky Reminds Shareholders of an Investigation into 4D Molecular Therapeutics, Inc. (FDMT) Regarding Potential Securities Fraud Allegations

Accesswire July 30, 2024

FDMT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Investors to Contact the Firm Today!

Accesswire July 30, 2024

Lost Money on 4D Molecular Therapeutics, Inc. (FDMT)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

Accesswire July 30, 2024

The Schall Law Firm Invites FDMT Investors To Join The Securities Fraud Investigation Of 4D Molecular Therapeutics Inc

Accesswire July 30, 2024

4D Molecular Therapeutics, Inc. (FDMT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Business Wire July 29, 2024

4D Molecular Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by 4D Molecular Therapeutics (FDMT)

Accesswire July 29, 2024

The Schall Law Firm Invites FDMT Investors To Participate In The Securities Fraud Investigation Of 4D Molecular Therapeutics Inc.

Accesswire July 29, 2024

4D Molecular Therapeutics, Inc. (FDMT) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights

Accesswire July 29, 2024

FDMT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Investors to Contact the Firm Today!

Accesswire July 29, 2024

4D Molecular Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by 4D Molecular Therapeutics (FDMT)

Accesswire July 28, 2024

FDMT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Investors to Contact the Firm Today!

Accesswire July 28, 2024

4D Molecular Therapeutics, Inc. (FDMT) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights

Accesswire July 26, 2024

The Schall Law Firm Invites FDMT Investors To Participate In The Securities Fraud Investigation Of 4D Molecular Therapeutics Inc.

Accesswire July 26, 2024

Investors who lost money on 4D Molecular Therapeutics, Inc. should contact Levi & Korsinsky about an ongoing investigation - FDMT

Accesswire July 26, 2024

FDMT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Stockholders to Contact the Firm!

Accesswire July 26, 2024

An Investigation Has Commenced on Behalf of 4D Molecular Therapeutics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your FDMT Losses.

Accesswire July 25, 2024

The Schall Law Firm Invites FDMT Investors To Join The Securities Fraud Investigation Of 4D Molecular Therapeutics Inc.

Accesswire July 25, 2024

FDMT ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of 4D Molecular Therapeutics, Inc. Shareholders Who Lost Money

Accesswire July 25, 2024

FDMT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Stockholders to Contact the Firm!

Accesswire July 25, 2024